Abstract
Objectives To explore factors affected untimely receiving intravitreal anti-Vascular endothelial growth factor (VEGF) injection based on the Capability, Opportunity and Motivation-Behavior (COM-B) model in patients with Diabetic Macular Edema (DME) and regard these factors as main targets for interventions.
Design An exploratory qualitative study was conducted using semi-structured interviews with patients with DME. The COM-B model was used to guide data collection and analysis.
Setting The study was carried out in outpatient department of ophthalmology in China.
Participants 24 patients with DME who experienced anti-VEGF treatment at least one injection within one year were recruited using convenience and purposed sampling.
Results The themes and subthemes were identified. Physical capability included (1) lack of knowledge, (2) high treatment expenditure, and psychological capability included prioritized glycemic control rather than anti-VEGF. Social opportunity included (1) no anti-VEGF available, (2) Recommended eyedrops, laser and oral drug but not mentioned intravitreal anti-VEGF injection, (3) As an optional therapy, selected more convenient treatment rather than anti-VEGF agents, and physical opportunity included (1) no confidence in treatment from doctor, (2) communication between doctors and patients. Reflective motivation included (1) outcome expectancies, and automatic motivation included (1) fear of injection, (2) fear of blindness.
Conclusion We should attach importance to these eleven factors, especially to effective interaction between doctors and patients, and doctor’s authoritative treatment advice, which interventions were based on in the future.
Strengths and limitations of this study
⇒ The qualitative design was used to understand factors affecting timely intravitreal anti-VEGF injections in patients with DME and to explore the potential measures to change them.
⇒The study highlighted the importance of efficient communication between clinicians and patients.
⇒The study didn’t consider other clinical variables, such as the severity and duration of diabetes, which should be included in the future studies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Shanghai Jiao Tong University School of Medicine: Nursing Development Program (SHJT-RC-002).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine gave ethical approval for this work(No. 2022-KY-021).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
